Incidence of Glaucome in Patients with Uveitis

P. Neri, Augusto Azuara-Blanco, John Vincent Forrester

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Purpose: To evaluate the incidence of glaucoma and elevation of intraocular pressure (IOP) in patients with inflammatory eye disease.

Methods: Retrospective review of medical records of 391 consecutive patients with uveitis attending a uveitis clinic of an academic Department of Ophthalmology from January 1999 to August 2002. Demographic, ocular and systemic variables were recorded. The diagnosis and treatment of uveitis were recorded. Uveitis was classified according to standard anatomic, etiological and clinical criteria. "Glaucoma" was defined as elevated IOP (>21 mm Hg) or glaucomatous optic nerve damage requiring medical and/or surgical anti-glaucoma treatment. Kaplan-Maier analysis and log-rank tests were used to evaluate and compare the incidence of glaucoma.

Results: The incidence of glaucoma as defined above at 3 and 12 months after acute uveitis was 7.6%. In patients with chronic uveitis (n = 337), the incidence of glaucoma at 1 and 5 years was 6.5% and 11.1%, respectively. There was no statistically significant difference in the incidence of glaucoma between different types of uveitis, idiopathic versus non-idiopathic, and among anterior, intermediate, posterior and panuveitis. Visual loss occurred more frequently in patients with glaucoma than in patients without glaucoma.

Conclusion: In patients with chronic inflammatory eye disease, the presence of glaucoma was associated with an increasing risk of visual loss. The incidence of glaucoma increased with time and was similar among the different types of uveitis.

Original languageEnglish
Pages (from-to)461-465
Number of pages4
JournalJournal of Glaucoma
Volume13
Issue number6
DOIs
Publication statusPublished - 2004

Keywords

  • glaucoma
  • uveitis
  • incidence
  • TERM-FOLLOW-UP
  • SECONDARY GLAUCOMA
  • POSTERIOR UVEITIS
  • CYCLOSPORINE-A
  • TRABECULECTOMY
  • MANAGEMENT
  • THERAPY
  • DISEASE
  • EYE

Cite this

Incidence of Glaucome in Patients with Uveitis. / Neri, P.; Azuara-Blanco, Augusto; Forrester, John Vincent.

In: Journal of Glaucoma, Vol. 13, No. 6, 2004, p. 461-465.

Research output: Contribution to journalArticle

Neri, P, Azuara-Blanco, A & Forrester, JV 2004, 'Incidence of Glaucome in Patients with Uveitis', Journal of Glaucoma, vol. 13, no. 6, pp. 461-465. https://doi.org/10.1097/01.ijg.0000146391.77618.d0
Neri, P. ; Azuara-Blanco, Augusto ; Forrester, John Vincent. / Incidence of Glaucome in Patients with Uveitis. In: Journal of Glaucoma. 2004 ; Vol. 13, No. 6. pp. 461-465.
@article{ef7e7a64e501486eba202df0771bc482,
title = "Incidence of Glaucome in Patients with Uveitis",
abstract = "Purpose: To evaluate the incidence of glaucoma and elevation of intraocular pressure (IOP) in patients with inflammatory eye disease.Methods: Retrospective review of medical records of 391 consecutive patients with uveitis attending a uveitis clinic of an academic Department of Ophthalmology from January 1999 to August 2002. Demographic, ocular and systemic variables were recorded. The diagnosis and treatment of uveitis were recorded. Uveitis was classified according to standard anatomic, etiological and clinical criteria. {"}Glaucoma{"} was defined as elevated IOP (>21 mm Hg) or glaucomatous optic nerve damage requiring medical and/or surgical anti-glaucoma treatment. Kaplan-Maier analysis and log-rank tests were used to evaluate and compare the incidence of glaucoma.Results: The incidence of glaucoma as defined above at 3 and 12 months after acute uveitis was 7.6{\%}. In patients with chronic uveitis (n = 337), the incidence of glaucoma at 1 and 5 years was 6.5{\%} and 11.1{\%}, respectively. There was no statistically significant difference in the incidence of glaucoma between different types of uveitis, idiopathic versus non-idiopathic, and among anterior, intermediate, posterior and panuveitis. Visual loss occurred more frequently in patients with glaucoma than in patients without glaucoma.Conclusion: In patients with chronic inflammatory eye disease, the presence of glaucoma was associated with an increasing risk of visual loss. The incidence of glaucoma increased with time and was similar among the different types of uveitis.",
keywords = "glaucoma, uveitis, incidence, TERM-FOLLOW-UP, SECONDARY GLAUCOMA, POSTERIOR UVEITIS, CYCLOSPORINE-A, TRABECULECTOMY, MANAGEMENT, THERAPY, DISEASE, EYE",
author = "P. Neri and Augusto Azuara-Blanco and Forrester, {John Vincent}",
year = "2004",
doi = "10.1097/01.ijg.0000146391.77618.d0",
language = "English",
volume = "13",
pages = "461--465",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Incidence of Glaucome in Patients with Uveitis

AU - Neri, P.

AU - Azuara-Blanco, Augusto

AU - Forrester, John Vincent

PY - 2004

Y1 - 2004

N2 - Purpose: To evaluate the incidence of glaucoma and elevation of intraocular pressure (IOP) in patients with inflammatory eye disease.Methods: Retrospective review of medical records of 391 consecutive patients with uveitis attending a uveitis clinic of an academic Department of Ophthalmology from January 1999 to August 2002. Demographic, ocular and systemic variables were recorded. The diagnosis and treatment of uveitis were recorded. Uveitis was classified according to standard anatomic, etiological and clinical criteria. "Glaucoma" was defined as elevated IOP (>21 mm Hg) or glaucomatous optic nerve damage requiring medical and/or surgical anti-glaucoma treatment. Kaplan-Maier analysis and log-rank tests were used to evaluate and compare the incidence of glaucoma.Results: The incidence of glaucoma as defined above at 3 and 12 months after acute uveitis was 7.6%. In patients with chronic uveitis (n = 337), the incidence of glaucoma at 1 and 5 years was 6.5% and 11.1%, respectively. There was no statistically significant difference in the incidence of glaucoma between different types of uveitis, idiopathic versus non-idiopathic, and among anterior, intermediate, posterior and panuveitis. Visual loss occurred more frequently in patients with glaucoma than in patients without glaucoma.Conclusion: In patients with chronic inflammatory eye disease, the presence of glaucoma was associated with an increasing risk of visual loss. The incidence of glaucoma increased with time and was similar among the different types of uveitis.

AB - Purpose: To evaluate the incidence of glaucoma and elevation of intraocular pressure (IOP) in patients with inflammatory eye disease.Methods: Retrospective review of medical records of 391 consecutive patients with uveitis attending a uveitis clinic of an academic Department of Ophthalmology from January 1999 to August 2002. Demographic, ocular and systemic variables were recorded. The diagnosis and treatment of uveitis were recorded. Uveitis was classified according to standard anatomic, etiological and clinical criteria. "Glaucoma" was defined as elevated IOP (>21 mm Hg) or glaucomatous optic nerve damage requiring medical and/or surgical anti-glaucoma treatment. Kaplan-Maier analysis and log-rank tests were used to evaluate and compare the incidence of glaucoma.Results: The incidence of glaucoma as defined above at 3 and 12 months after acute uveitis was 7.6%. In patients with chronic uveitis (n = 337), the incidence of glaucoma at 1 and 5 years was 6.5% and 11.1%, respectively. There was no statistically significant difference in the incidence of glaucoma between different types of uveitis, idiopathic versus non-idiopathic, and among anterior, intermediate, posterior and panuveitis. Visual loss occurred more frequently in patients with glaucoma than in patients without glaucoma.Conclusion: In patients with chronic inflammatory eye disease, the presence of glaucoma was associated with an increasing risk of visual loss. The incidence of glaucoma increased with time and was similar among the different types of uveitis.

KW - glaucoma

KW - uveitis

KW - incidence

KW - TERM-FOLLOW-UP

KW - SECONDARY GLAUCOMA

KW - POSTERIOR UVEITIS

KW - CYCLOSPORINE-A

KW - TRABECULECTOMY

KW - MANAGEMENT

KW - THERAPY

KW - DISEASE

KW - EYE

U2 - 10.1097/01.ijg.0000146391.77618.d0

DO - 10.1097/01.ijg.0000146391.77618.d0

M3 - Article

VL - 13

SP - 461

EP - 465

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

IS - 6

ER -